TSX-V:GENX - TSX Venture Exchange - CA37232A1093 - Common Stock - Currency: CAD
TSX-V:GENX (3/5/2025, 7:00:00 PM)
0.04
0 (0%)
The current stock price of GENX.CA is 0.04 CAD. In the past month the price decreased by -20%. In the past year, price decreased by -63.64%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
JWEL.CA | JAMIESON WELLNESS INC | 23.9 | 1.20B | ||
LOVE.CA | CANNARA BIOTECH INC | 18.71 | 118.74M | ||
HILL.CA | HILL STREET BEVERAGE CO INC | N/A | 1.05M | ||
VPI.CA | VITALITY PRODUCTS INC | N/A | 1.04M |
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. The firm is focused on the research, development, manufacturing, licensing and selling of novel and healthcare products. These products include evidence-based, proprietary over the counter (OTC) nutraceuticals, and other single molecule generic drugs. The firm has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid soft gels, seal oil soft gels, marine lipid soft gels, Lecithin soft gels, fish oil soft gels, EPO soft gels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and Artificial Tearssingle-molecule.
GENIX PHARMACEUTICALS CORP
Suite 300, 1055 West Hastings St
Vancouver BRITISH COLUMBIA V6E 1J8 CA
CEO: Sina Salehi Pirooz
Employees: 0
Company Website: https://genixpharm.com/
Investor Relations: https://genixpharm.com/pages/investors
Phone: 16046096198
The current stock price of GENX.CA is 0.04 CAD.
The exchange symbol of GENIX PHARMACEUTICALS CORP is GENX and it is listed on the TSX Venture Exchange exchange.
GENX.CA stock is listed on the TSX Venture Exchange exchange.
GENIX PHARMACEUTICALS CORP (GENX.CA) has a market capitalization of 2.37M CAD. This makes GENX.CA a Nano Cap stock.
GENIX PHARMACEUTICALS CORP (GENX.CA) currently has 0 employees.
GENIX PHARMACEUTICALS CORP (GENX.CA) has a support level at 0.03 and a resistance level at 0.04. Check the full technical report for a detailed analysis of GENX.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GENX.CA does not pay a dividend.
GENIX PHARMACEUTICALS CORP (GENX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
Over the last trailing twelve months GENX.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -353.02% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1717.18% | ||
ROE | N/A | ||
Debt/Equity | N/A |